Lung cancer data collection and quality of life assessment in Lyon
Prospective Longitudinal Cohort Associated to Blood Collection, Pathological Samples Collection, and Radiological and Pathological Imaging Collection
This study is collecting health information and quality of life surveys from lung cancer patients at the Lyon University Hospital to better understand their treatment and well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Pierre-Bénite) |
| Trial ID | NCT05267041 on ClinicalTrials.gov |
What this trial studies
This study involves the collection of data from patients treated for thoracic cancers, specifically lung cancer, at the Lyon University Hospital. It includes prospective longitudinal cohort data, which encompasses blood samples, pathological samples, and imaging data. Patients will also complete quality of life questionnaires to assess their well-being throughout their treatment. The aim is to gather comprehensive information that can enhance understanding and treatment of lung cancer.
Who should consider this trial
Good fit: Ideal candidates are patients treated for thoracic cancers, including non-small cell lung cancer, small cell lung cancer, and mesothelioma, at the Lyon University Hospital.
Not a fit: Patients who refuse to participate or are under 30 kg may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into lung cancer treatment and improve patient quality of life.
How similar studies have performed: While this approach is focused on data collection and quality of life, similar studies have shown promise in enhancing patient outcomes in lung cancer treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma…
* Diagnosis can be done:
* By cytology or pathologic assessment
* Or by multidisciplinary team meeting decision:
* Irradiation without morpho-metabolic sampling
* Treatment without sampling based on non-invasive molecular data
Exclusion Criteria:
\- Refusal to participate
For optional blood sampling :
* \< 30 kg for blood collection
* No blood sampling schedule for care
Where this trial is running
Pierre-Bénite
- Centre Hospitalier Lyon Sud — Pierre-Bénite, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.